SEC recommends India's first indigenously developed vaccine against cervical cancer for 9 to 26-year age group

Jun 15, 2022

New Delhi [India], June 15 : The subject expert committee meeting that was scheduled today to discuss Serum Institute of India's (SII) indigenously developed...

SEC to discuss India's first indigenously developed vaccine against cervical cancer

Jun 15, 2022

New Delhi [India] June 15 : The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India...

SII launches India's first fully indigenously developed pneumococcal vaccine

Dec 28, 2020

Pune (Maharashtra) [India], December 28 : Serum Institute of India, the largest vaccine manufacturer in the world by doses, announces the launch of India's...

Indian Immunologicals Ltd launches India's first indigenously developed Hepatitis A vaccine, 'Havisure'

Jan 19, 2024

Indian Immunologicals Ltd. (IIL), a wholly-owned subsidiary of the National Dairy Development Board (NDDB) and a biopharmaceutical company in India, launched India's first indigenously...

Serum Institute of India launches first made-in-India HPV vaccine for cervical cancer

Jan 24, 2023

The indigenously developed vaccine, "CERVAVAC" was announced for the prevention of cervical cancer.

India's first indigenously developed Cervavac vaccine will help prevent Cervical cancer: Jitendra Singh

Jan 26, 2023

Serum Institute of India Director Prakash Kumar Singh on Thursday presented Made in India HPV Vaccine Cervavac to Union Minister Jitendra Singh at the...